Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers

Safety and Efficacy of Switching Psychiatric Patients from a Delayed-Release to an Extended-Release Formulation of Divalproex Sodium

Journal of Clinical Psychopharmacology ◽

10.1097/00004714-200304000-00010 ◽

2003 ◽

Vol 23 (2) ◽

pp. 176-181 ◽

Cited By ~ 20

Author(s):

Robert Lynn Horne ◽

Cedric Cunanan

Keyword(s):

Extended Release ◽

Psychiatric Patients ◽

Divalproex Sodium ◽

Release Formulation ◽

Safety And Efficacy ◽

A Study of the Safety, Efficacy, and Tolerability of Switching From the Standard Delayed Release Preparation of Divalproex Sodium to the Extended Release Formulation in Patients With Schizophrenia

Journal of Clinical Psychopharmacology ◽

10.1097/01.jcp.0000125687.27961.64 ◽

2004 ◽

Vol 24 (3) ◽

pp. 255-259 ◽

Cited By ~ 15

Author(s):

Leslie Citrome ◽

Fabien Tremeau ◽

Pe Shein Wynn ◽

Biman Roy ◽

Hassan Dinakar

Keyword(s):

Extended Release ◽

Divalproex Sodium ◽

Release Formulation ◽

Delayed Release ◽

Release Preparation

4.23 PIVOTAL PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF HLD200, A NOVEL DELAYED-RELEASE AND EXTENDED-RELEASE FORMULATION OF METHYLPHENIDATE, IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2016.09.218 ◽

2016 ◽

Vol 55 (10) ◽

pp. S170

Author(s):

Valerie K. Arnold ◽

Norberto J. DeSousa ◽

Bev Incledon ◽

Floyd R. Sallee ◽

Timothy E. Wilens ◽

...

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Extended Release ◽

Efficacy And Safety ◽

Phase 3 ◽

Pivotal Phase ◽

Release Formulation ◽

Hyperactivity Disorder ◽

Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers

Clinical Pharmacology Advances and Applications ◽

10.2147/cpaa.s70831 ◽

2015 ◽

pp. 1

Author(s):

Stephen Farr ◽

Cynthia Robinson ◽

Christopher M. Rubino

Keyword(s):

Healthy Volunteers ◽

Extended Release ◽

Release Formulation ◽

0172 Divalproex sodium (extended release formulation) as a monotherapy in generalized tonic clonic seizure

Journal of the Neurological Sciences ◽

10.1016/s0022-510x(05)80545-3 ◽

2005 ◽

Vol 238 ◽

pp. S143

Keyword(s):

Extended Release ◽

Clonic Seizure ◽

Tonic Clonic Seizure ◽

Divalproex Sodium ◽

Release Formulation ◽

Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation

Biopharmaceutics & Drug Disposition ◽

10.1002/bdd.420 ◽

2004 ◽

Vol 25 (8) ◽

pp. 345-352 ◽

Cited By ~ 18

Author(s):

Sandeep Dutta ◽

Yiming Zhang

Keyword(s):

Extended Release ◽

Release Formulation ◽

Immediate switching from a chrono to an extended-release formulation of divalproex sodium: A two-part study in patients with controlled epilepsy

Annals of Indian Academy of Neurology ◽

10.4103/0972-2327.41886 ◽

2008 ◽

Vol 11 (2) ◽

pp. 127

Author(s):

Asad Abbas ◽

Rakesh Shukla ◽

Sanjay Prakash

Keyword(s):

Extended Release ◽

Divalproex Sodium ◽

Release Formulation ◽

Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers

Drug Design Development and Therapy ◽

10.2147/dddt.s53027 ◽

2014 ◽

pp. 123 ◽

Cited By ~ 7

Author(s):

Seonghae Yoon ◽

Howard Lee ◽

Tae-Eun Kim ◽

SeungHwan Lee ◽

Dong-Hyun Chee ◽

...

Keyword(s):

Steady State ◽

Healthy Volunteers ◽

Pharmacokinetic Study ◽

Extended Release ◽

Immediate Release ◽

Reference Formulation ◽

Release Formulation ◽

Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans

Letters in Drug Design & Discovery ◽

10.2174/1570180814666161216121558 ◽

2017 ◽

Vol 14 (7) ◽

Cited By ~ 1

Author(s):

Yuan-Lin Guo ◽

Wei Zhang ◽

Qian Dong ◽

Geng Liu ◽

Cheng-Gang Zhu ◽

...

Keyword(s):

Extended Release ◽

Release Formulation ◽

A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.362 ◽

2017 ◽

Vol 7 (2) ◽

pp. 151-159 ◽

Cited By ~ 1

Author(s):

Ann Childress ◽

Jeffrey G. Stark ◽

Russ McMahen ◽

Dorothy Engelking ◽

Carolyn Sikes

Keyword(s):

Extended Release ◽

Healthy Adults ◽

Release Formulation ◽

Orally Disintegrating Tablets